These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10654817)

  • 1. Insulin-like growth factor I treatment for end-stage renal disease at the end of the millennium.
    Hammerman MR
    Curr Opin Nephrol Hypertens; 2000 Jan; 9(1):1-3. PubMed ID: 10654817
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of growth factors to increase glomerular filtration rate in chronic renal failure patients.
    Miller SB; Rabkin R
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):401-4. PubMed ID: 9263692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone and insulin-like growth factor I on renal growth and function.
    Hammerman MR; Miller SB
    J Pediatr; 1997 Jul; 131(1 Pt 2):S17-9. PubMed ID: 9255221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure.
    Fervenza FC; Friedlaender MM; Ike JO; Rabkin R
    Ren Fail; 1998 Mar; 20(2):349-56. PubMed ID: 9574462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of growth factors in renal failure.
    Hammerman MR; Miller SB
    J Am Soc Nephrol; 1994 Jul; 5(1):1-11. PubMed ID: 7948775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the clinical uses of insulin-like growth factor-I in acute and chronic renal failure?
    Hammerman MR
    Pediatr Nephrol; 1994 Oct; 8(5):544. PubMed ID: 7818998
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of growth factors in chronic renal failure.
    Vijayan A; Behrend T; Miller SB
    Curr Opin Nephrol Hypertens; 2000 Jan; 9(1):5-10. PubMed ID: 10654818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure.
    Vijayan A; Franklin SC; Behrend T; Hammerman MR; Miller SB
    Am J Physiol; 1999 Apr; 276(4):R929-34. PubMed ID: 10198369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin-like growth factor I against chronic renal failure].
    Pedersen EB
    Ugeskr Laeger; 1993 Jul; 155(28):2217. PubMed ID: 8328087
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of IGF-I on renal function in end-stage chronic renal failure.
    Miller SB; Moulton M; O'Shea M; Hammerman MR
    Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous infusion of recombinant human growth hormone (rhGH) improved renal function in a patient with Sheehan's syndrome associated with chronic renal failure.
    Sohmiya M; Nishiki M; Kato Y
    Endocr J; 1999 Mar; 46 Suppl():S39-42. PubMed ID: 12054116
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
    Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
    Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 resistance in chronic renal failure: current evidence and possible mechanisms.
    Ding H; Qing DP; Kopple JD
    Kidney Int Suppl; 1997 Nov; 62():S45-7. PubMed ID: 9350679
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein (IGFBP) displacers: relevance to the treatment of renal disease.
    Roelfsema V; Lane MH; Clark RG
    Pediatr Nephrol; 2000 Jul; 14(7):584-8. PubMed ID: 10912523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis.
    Kapila P; Jones J; Rees L
    Pediatr Nephrol; 2001 Dec; 16(12):1099-104. PubMed ID: 11793109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology and pathophysiology of IGF-I in the kidney.
    Hirschberg R
    Adv Exp Med Biol; 1993; 343():345-66. PubMed ID: 8184743
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Adjuvant Urinary Diversion versus Valve Ablation Alone on Progression from Chronic to End Stage Renal Disease in Posterior Urethral Valves: A Single Institution 15-Year Time-to-Event Analysis.
    Chua ME; Ming JM; Carter S; El Hout Y; Koyle MA; Noone D; Farhat WA; Lorenzo AJ; Bägli DJ
    J Urol; 2018 Mar; 199(3):824-830. PubMed ID: 29061539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.
    Ding H; Kopple JD; Cohen A; Hirschberg R
    J Clin Invest; 1993 May; 91(5):2281-7. PubMed ID: 8486787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.